Single-channel activity and expression of atrial L-type Ca2+ channels in patients with latent hyperthyroidism

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Kreuzberg, U ^a   Theissen, P ^a   Schicha, H ^a   Schroder F ^a   Mehlhorn, U ^a   De Vivie, E R ^a   Boknik P ^b   Neumann, J ^b   Grohe C ^c   Herzig, S ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Human myocytes; Patch clamp; Phospholamban; Sarco(endo) plasmic reticulum calcium adenosinetriphosphatase; Western blot

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL; CALCIUM ION; CALSEQUESTRIN; PHOSPHOLAMBAN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPERTHYROIDISM; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; THYROID DISEASE;

EID: 0034065792     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.3.h723     Document Type: Article

References (31)

1. Binah, O., I. Rubinstein, and E. Gilat. Effects of thyroid hormone on the action potential and membrane currents of guinea-pig ventricular myocytes. Pflügers Arch. 409: 214-216, 1987.
2. Bruce, S. A., D. C. Rangedara, R. R. Lewis, and D. Corless. Hyperthyroidism in elderly patients with atrial fibrillation and normal thyroid hormone measurements. J. R. Soc. Med. 80: 74-76, 1987.
3. 2 -ATPase and α-myosin heavy chain in rat hearts. J. Clin. Invest. 100: 1742-1749, 1997.
4. Drago, G. A., and J. Colyer. Discrimination between two sites of phosphorylation on adjacent amino acids by phosphorylation site-specific antibodies to phospholamban. J. Biol. Chem. 269: 25073-25077, 1994.
5. Forfar, J. C., H. C. Miller, and A. D. Toft. Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. Am. J. Cardiol. 44: 9-12, 1979.
6. Grohé, C., J. Mittler, P. Doevendans, R. Meyer, K. Löbbert, and H. Vetter. Estrogen modulates cardiac expression of proteins involved in calcium homeostasis in vivo (Abstract). Circulation 98, Suppl. I-747, 1998.
7. Han, J., C. Leem, I. So, E. Kim, S. Hong, W. Ho, H. Sung, and Y. E. Earm. Effects of thyroid hormone on the calcium current and isoprenaline-induced background current in rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 26: 925-935, 1994.
8. Handrock, R., F. Schröder, S. Hirt, A. Haverich, C. Mittmann, and S. Herzig. Single-channel properties of L-type calcium channels from failing human ventricle. Cardiovasc. Res. 37: 445-455, 1998.
9. 2+-ATPase gene. Demonstration that retinoid X receptor binds 5′ to thyroid hormone receptor in response element 1. J. Biol. Chem. 269: 13021-13029, 1994.
10. Herzig, S., P. Patil, J. Neumann, C.-M. Staschen, and D. T. Yue. Mechanisms of β-adrenergic stimulation of cardiac Ca channels revealed by discrete-time Markov analysis of slow gating. Biophys. J. 65: 1599-1612, 1993.
11. Hirano, Y., K. Suzuki, N. Yamawake, and M. Hiraoka. Multiple kinetic effects of β-adrenergic stimulation on single cardiac L-type Ca channels. Am. J. Physiol. Cell Physiol. 266: C1714-C1721, 1994.
12. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J. Clin. Invest. 101: 1385-1393, 1998.
13. Kaasik, A., A. Minajeva, K. Paju, M. Eimre, and E. K. Seppet. Thyroid hormones differentially affect sarcoplasmic reticulum function in rat atria and ventricles. Mol. Cell. Biochem. 176: 119-126, 1997.
14. 2+-cycling proteins in the baboon. Implications for the force-frequency and relaxation-frequency relationships. Circ. Res. 79: 727-735, 1996.
15. Kim, D., T. W. Smith, and J. D. Marsh. Effect of thyroid hormone on slow calcium channel function in cultured chick ventricular cells. J. Clin. Invest. 80: 88-94, 1987.
16. 2+-ATPase and decreasing phospholamban expression. J. Mol. Cell. Cardiol. 26: 1145-1154, 1994.
17. Kiss, E., G. Jakab, E. G. Kranias, and I. Edes. Thyroid hormone-induced alterations in phospholamban protein expression. Circ. Res. 75: 245-251, 1994.
18. 3 cells. Mol. Pharmacol. 42: 666-670, 1992.
19. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
20. Lowry O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
21. MacDougall L. K., L. R. Jones, and P. K. Cohen. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur. J. Biochem. 196: 725-734, 1991.
22. Monreal, M., E. Lafoz, M. Foz, A. Sanmarti, I. Salinas, L. Audi, and E. Viver. Occult thyrotoxicosis in patients with atrial fibrillation and an acute arterial embolism. Angiol. Nov. 39: 981-985, 1988.
23. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657, 1994.
24. Neumann J., R. C. Gupta, W. Schmitz, H. Scholz, A. C. Nairn, and A. M. Watanabe. Evidence for isoproterenolinduced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ. Res. 69: 1450-1457, 1991.
25. Rubinstein, I., and O. Binah. Thyroid hormone modulates membrane currents in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch. Pharmacol. 340: 705-711, 1989.
26. Sawin, C. T., A. Geller, P. A. Wolf, A. J. Belanger, E. Baker, P. Bacharach, P. W. F. Wilson, E. J. Benjamin, and R. B. D'Agostino. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 331: 1249-1252, 1994.
27. Schröder, F., R. Handrock, D. J. Beuckelmann, S. Hirt, R. Hullin, L. Priebe, R. H. G. Schwinger, J. Weil, and S. Herzig. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 98: 969-976, 1998.
28. Surks, M. I., and E. Ocampo. Subclinical thyroid disease. Am. J. Med. 100: 217-223, 1996.
29. 31P-magnetic resonance spectroscopy: impaired energy metabolism in latent hyperthyroidism. Nucl. Med. 32: 134-139, 1993.
30. Utiger, R. D. Subclinical hyperthyroidism - just a low serum thyrotropin concentration, or something more? N. Engl. J. Med. 331: 1302-1303, 1994.
31. Wiersinga, W. M. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Neth. J. Med. 46: 197-204, 1995.